Morningstar's AB Biotics Stock Analysis
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
AB Biotics's Company Profile
AB Biotics is a biotechnology company engaged in the research and development of probiotics and specialty dietary supplements. It manufactures drugs for cardiometabolic, oral care pediatrics, gastrointestinal, gynecology and urology, dermatology and immunology areas. The company also offers a wide range of genomic services including genetic tests in the fertility and pain treatment fields. Its product offerings include AB-Immuno, AB-sakei 65, AB-Kolicare, AB- Cyscare, AB- Dentalac Pro, AB- Dentalac Junior, among others.
Barcelona, 08172, Spain